Trials / Completed
CompletedNCT01390805
Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 462 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect and assess information on proper use of valaciclovir regarding safety and efficacy of long-term use in suppressive therapy for subjects with recurrent genital herpes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valaciclovir Hydrochloride. |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2009-04-01
- Completion
- 2011-03-01
- First posted
- 2011-07-11
- Last updated
- 2017-05-16
Source: ClinicalTrials.gov record NCT01390805. Inclusion in this directory is not an endorsement.